We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
Read MoreHide Full Article
Danaher (DHR - Free Report) closed the most recent trading day at $326.58, moving +0.97% from the previous trading session. This change outpaced the S&P 500's 0.14% gain on the day. Elsewhere, the Dow gained 0.25%, while the tech-heavy Nasdaq lost 0.34%.
Coming into today, shares of the industrial and medical device maker had gained 0.56% in the past month. In that same time, the Conglomerates sector lost 0.25%, while the S&P 500 gained 4.32%.
Investors will be hoping for strength from Danaher as it approaches its next earnings release, which is expected to be January 27, 2022. The company is expected to report EPS of $2.50, up 20.19% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $7.76 billion, up 14.82% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $9.85 per share and revenue of $29.07 billion, which would represent changes of +56.1% and +30.47%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Danaher. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.46% higher. Danaher currently has a Zacks Rank of #2 (Buy).
In terms of valuation, Danaher is currently trading at a Forward P/E ratio of 32.84. For comparison, its industry has an average Forward P/E of 18.01, which means Danaher is trading at a premium to the group.
Investors should also note that DHR has a PEG ratio of 1.51 right now. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Diversified Operations industry currently had an average PEG ratio of 1.75 as of yesterday's close.
The Diversified Operations industry is part of the Conglomerates sector. This group has a Zacks Industry Rank of 98, putting it in the top 39% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
Danaher (DHR - Free Report) closed the most recent trading day at $326.58, moving +0.97% from the previous trading session. This change outpaced the S&P 500's 0.14% gain on the day. Elsewhere, the Dow gained 0.25%, while the tech-heavy Nasdaq lost 0.34%.
Coming into today, shares of the industrial and medical device maker had gained 0.56% in the past month. In that same time, the Conglomerates sector lost 0.25%, while the S&P 500 gained 4.32%.
Investors will be hoping for strength from Danaher as it approaches its next earnings release, which is expected to be January 27, 2022. The company is expected to report EPS of $2.50, up 20.19% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $7.76 billion, up 14.82% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $9.85 per share and revenue of $29.07 billion, which would represent changes of +56.1% and +30.47%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Danaher. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.46% higher. Danaher currently has a Zacks Rank of #2 (Buy).
In terms of valuation, Danaher is currently trading at a Forward P/E ratio of 32.84. For comparison, its industry has an average Forward P/E of 18.01, which means Danaher is trading at a premium to the group.
Investors should also note that DHR has a PEG ratio of 1.51 right now. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Diversified Operations industry currently had an average PEG ratio of 1.75 as of yesterday's close.
The Diversified Operations industry is part of the Conglomerates sector. This group has a Zacks Industry Rank of 98, putting it in the top 39% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.